Home › Funds › ING GROEP NV › ABBV

ING GROEP NV position in ABBV

ABBVIE INC · Health Care

ING GROEP NV reported holding 452,394 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$113.8M, representing 0.56% of its reported portfolio and ranking #35 among its reported holdings. ING GROEP NV has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)452.39K sh
Reported value held$113.84M
Portfolio Weight0.56%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ING GROEP NV's ABBV position evolved

ING GROEP NV first disclosed a stake in ABBV in Q3 2023 at 303,668 shares (US$45.3M). The position peaked in Q3 2025 at 921,501 shares, worth US$213.4M. Across 12 filings, ING GROEP NV increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 452,394 shares valued at US$113.8M — a reduction of -69,972 shares quarter over quarter.. Notable position changes include a 65% increase in Q1 2024 (shares fell 5% over the following quarter), a 79% increase in Q4 2024 (shares rose 19% over the following quarter), a 134% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 303.67K $45.26M New
Q4 2023 264.43K $40.98M Reduce
Q1 2024 435.66K $79.33M Add
Q2 2024 431.35K $73.98M Reduce
Q3 2024 334.78K $66.11M Reduce
Q4 2024 598.34K $106.32M Add
Q1 2025 540.30K $113.20M Reduce
Q2 2025 393.31K $73.01M Reduce
Q3 2025 921.50K $213.36M Add
Q4 2025 791.03K $180.74M Reduce
Q1 2026 522.37K $113.61M Reduce
Q2 2026 452.39K $113.84M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has ING GROEP NV held ABBV?

ING GROEP NV has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ING GROEP NV's current position in ABBV?

As of Q2 2026, ING GROEP NV holds 452.39K shares of ABBV (ABBVIE INC), valued at $113.84M, representing 0.56% of its reported portfolio and ranking #35.

Has ING GROEP NV been buying or selling ABBV?

In the latest 13F filing (Q2 2026), ING GROEP NV reduced its position in ABBV. The position peaked in Q3 2025 at 921.50K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.